Sleep Disorders News

19 Aug 20267:15 am

Pharmaceuticals19 Aug 2026 · 7:15 am7:15 am

FDA Approves Orzeyful, First Drug to Treat a Cause of Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved Orzeyful (oveporexton), the first drug to treat a cause of narcolepsy by targeting the orexin pathway.

17 Aug 202610:34 pm

Science17 Aug 2026 · 10:34 pm10:34 pm

Create visual

First-of-its-Kind Narcolepsy Drug Targets Root Cause, Paving Way for New Brain Therapies

A new narcolepsy drug, Orzeyful, has been developed that targets the root cause of the sleep disorder rather than just its symptoms, potentially opening doors f

Sleep Disorders News

#Sleep Disorders

FDA Approves Orzeyful, First Drug to Treat a Cause of Narcolepsy Type 1

First-of-its-Kind Narcolepsy Drug Targets Root Cause, Paving Way for New Brain Therapies

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs